Anti-HIV-1 gp120 Recombinant Antibody
-
产品编号
YR1547
-
别名
科研级 Elipovimab (依帕韦单抗 ), Anti-HIV-1 gp120 Recombinant Antibody, Research Grade Elipovimab
-
规格
- 1mg
- 5mg
Alias | 科研级 Elipovimab (依帕韦单抗 ), Anti-HIV-1 gp120 Recombinant Antibody, Research Grade Elipovimab |
Catalog Number | YR1547 |
Molecular Name | Elipovimab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Lambda |
Formulation | PBS, pH7.5 |
Background | Elipovimab (formerly known as GS-9722) is a first in class of effector-enhanced broadly neutralizing HIV-1 antibodies for the targeted elimination of HIV infected cells and is as of 2020 in phase 1b clinical testing, designed with the goal of reducing or eliminating the HIV reservoir in patients. |
CAS Number | 2101210-43-7 |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | HIV-1 gp120[Human immunodeficiency Virus 1] |